FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1487-1490 November 16, 2000 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Despite advances in medical therapy and improvements in techniques for myocardial revascularization, the prognosis remains poor for patients with ischemic cardiomyopathy, which is characterized by extensive coronary artery disease and diminished global left ventricular function. Five-year rates of survival range from 50 to 60 percent. Survival is worse as the left ventricular ejection fraction decreases, the extent of coronary artery disease increases, and the age of the patient increases.¹ Chronic left ventricular dysfunction in patients with ischemic cardiomyopathy most often results from either scarring, as a consequence of myocardial necrosis, or myocardial hibernation. The presence of myocardial hibernation suggests that . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Selvanayagam, J. B., Kardos, A., Francis, J. M., Wiesmann, F., Petersen, S. E., Taggart, D. P., Neubauer, S. (2004). Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization. Circulation 110: 1535-1541 [Abstract] [Full Text]